v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income $ 288,262 $ 94,948
Adjustments to reconcile net income to net cash (used) provided in operating activities:    
Investment income (41,402) (3,785)
Net realized and unrealized (gain) loss from consolidated funds’ investments (166,366) 65,207
Accretion of original issue and market discount of consolidated funds’ investments, net 1,039 (33,771)
Income distributions from corporate investments in funds and companies 14,254 148,591
Cash flows due to changes in operating assets and liabilities:    
Net cash (used in) provided by operating activities (164,539) 540,008
Cash flows from investing activities:    
Distributions and proceeds from corporate investments in funds and companies 3,500 49,443
Net cash provided by investing activities 3,500 49,443
Cash flows from financing activities:    
Capital (distributions) contributions, net 59,716 119,433
Net cash used in financing activities 223,190 (751,448)
Effect of exchange rate changes on cash    
Effect of exchange rate changes on cash 2,566 331
Net increase (decrease) in cash and cash-equivalents 64,717 (161,666)
Cash and Cash Equivalents    
Cash and cash-equivalents, beginning balance 190,740 449,851
Cash and cash-equivalents, ending balance 255,457 288,185
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]    
Total cash and cash-equivalents 255,457 288,185
Oaktree    
Cash flows due to changes in operating assets and liabilities:    
Increase in other assets (8,338) (14,629)
Increase in net due from affiliates 0 (338)
Increase (decrease) in accrued compensation expense 247 (169)
Increase (decrease) in accounts payable, accrued expenses and other liabilities 326 (325)
Cash flows from financing activities:    
Distributions to Class A unitholders (41,034) (341,382)
Distributions to preferred unitholders (13,658) (13,658)
Cash and Cash Equivalents    
Cash and cash-equivalents, ending balance 11,557 15,207
Supplemental disclosure of non-cash investing and financing activities    
Distribution of equity interest in OCG NTR Holdings, LLC 317,356 0
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]    
Total cash and cash-equivalents 11,557 15,207
Consolidated Funds    
Cash flows due to changes in operating assets and liabilities:    
Increase (decrease) in accounts payable, accrued expenses and other liabilities (798) (362)
Decrease in dividends and interest receivable 1,791 12,088
Increase in receivables for investments sold (606) (16,293)
Decrease (increase) in other assets 34,971 (22,172)
Increase (decrease) in payables for investments purchased 72,064 (1,933)
Purchases of investments (1,398,785) (1,123,784)
Proceeds from maturities and sales of investments 1,038,802 1,436,735
Cash flows from financing activities:    
Contributions from non-controlling interests 260,384 633,232
Distributions to non-controlling interests (221,806) (674,390)
Borrowings on credit facilities 599,538 545,602
Repayments on credit facilities (419,950) (1,020,285)
Cash and Cash Equivalents    
Cash and cash-equivalents, ending balance 243,900 272,978
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]    
Total cash and cash-equivalents $ 243,900 $ 272,978